Dolutegravir (DTG) is widely available in Ukraine due to advocacy work. It provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access to life-saving treatment in the country.
ITPC is proud to share its 2018 Annual Review – Turning Vision into Reality You can read the online summary...
On 22-27 July 2018, ITPC was in Amsterdam in the Netherlands for the 2018 International AIDS Conference (AIDS 2018). With support from the...
WATCH OUR NEW VIDEO – “JOIN THE FIGHT” ITPC was born in 2003 when a group of 125 treatment activists from...
ITPC is proud to share its 2017 Annual Review, titled What Community Activism Can Achieve. The report highlights our successes, challenges, and...
On 22-26 July 2017, ITPC Global, Regional Directors from ITPC LATCA and ITPC MENA, and representatives from ITPCru were in...
